In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Ingram Micro's current price trades 53% below its PERT-weighted fair value, indicating potential undervaluation supported by strong DCF and EV/EBITDA estimates. Financial health scores reveal fair liquidity but weak profitability and efficiency, heightening operational risk. Monte Carlo analysis shows moderate downside risk (13.9%) with significant valuation volatility (31.5% coefficient of variation).